354
17. MacAskill W. Doing good better: effective altruism and a radical new way to make a difference. London: Guardian Faber Publishing; 2015.
18. Allen AM, Jung AM, Lemieux AM, Alexander AC, Allen SS, Ward KD, et al. Stressful life
events are associated with perinatal cigarette smoking. Prev Med. 2019;118:264–71.
19. Boyko EJ, Trone DW, Peterson AV, Jacobson IG, Littman AJ, Maynard C, et al. Longitudinal
investigation of smoking initiation and relapse among younger and older US military personnel. Am J Public Health. 2015;105(6):1220–9.
20. Holliday E, Gould TJ. Nicotine, adolescence, and stress: a review of how stress can modulate the negative consequences of adolescent nicotine abuse. Neurosci Biobehav Rev.
2016;65:173–84.
21. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the
United States, 2011-2012. JAMA. 2014;311(8):806–14.
22. Gore AC, Chappell V, Fenton S, Flaws JA, Nadal A, Prins GS, et al. EDC-2: the Endocrine
Society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev.
2015;36(6):E1–E150.
23. Ribeiro E, Ladeira C, Viegas S. EDCs mixtures: a stealthy hazard for human health? Toxics.
2017;5(1):5.
24. Maradonna F, Carnevali O. Lipid metabolism alteration by endocrine disruptors in animal
models: an overview. Front Endocrinol. 2018;9:654.
25. Street ME, Angelini S, Bernasconi S, Burgio E, Cassio A, Catellani C, et al. Current knowledge on endocrine disrupting chemicals (EDCs) from animal biology to humans, from pregnancy to adulthood: highlights from a national italian meeting. Int J Mol Sci. 2018;19(6):1647.
26. Grün F, Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as
emerging factors in the obesity crisis. Rev Endocr Metab Disord. 2007;8(2):161–71.
27. Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, et al. Metabolism
disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017;68:3–33.
28. Sohn J-W. Network of hypothalamic neurons that control appetite. BMB Rep. 2015;48(4):229.
29. Le Magueresse-Battistoni B, Labaronne E, Vidal H, Naville D. Endocrine disrupting chemicals in mixture and obesity, diabetes and related metabolic disorders. World J Biol Chem.
2017;8(2):108.
30. An HM, Tan YL, Tan SP, Shi J, Wang ZR, Yang FD, et al. Smoking and serum lipid profiles in
schizophrenia. Neurosci Bull. 2016;32(4):383–8. Epub 2016/03/29. eng.
31. Hallit S, Zoghbi M, Hallit R, Youssef L, Costantine R, Kheir N, et al. Effect of exclusive cigarette smoking and in combination with waterpipe smoking on lipoproteins. J Epidemiol Glob
Health. 2017;7(4):269–75. Epub 2017/11/08. eng.
32. Jain RB, Ducatman A. Associations between smoking and lipid/lipoprotein concentrations
among US adults aged >/=20 years. J Circ Biomark. 2018;7:1849454418779310. Epub
2018/06/15. eng.
33. Tonstad S. Cigarette smoking, smoking cessation, and diabetes. Diabetes Res Clin Pract.
2009;85(1):4–13. Epub 2009/05/12. eng.
34. Maddatu J, Anderson-Baucum E, Evans-Molina C. Smoking and the risk of type 2 diabetes.
Transl Res. 2017;184:101–7. Epub 2017/03/25. eng.
35. Xie XT, Liu Q, Wu J, Wakui M. Impact of cigarette smoking in type 2 diabetes development.
Acta Pharmacol Sin. 2009;30(6):784–7. Epub 2009/05/13. eng.
36. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis. 2003;45(5):405–13. Epub
2003/04/22. eng.
37. Lind PM, Lind L. Endocrine-disrupting chemicals and risk of diabetes: an evidence-based
review. Diabetologia. 2018;61(7):1495–502.
38. Fabricio G, Malta A, Chango A, Mathias PCDF. Environmental contaminants and pancreatic
beta-cells. J Clin Res Pediatr Endocrinol. 2016;8(3):257.
39. Malinska D, Wieckowski MR, Michalska B, Drabik K, Prill M, Patalas-Krawczyk P, et al.
Mitochondria as a possible target for nicotine action. J Bioenerg Biomembr. 2019;51(4):259–
76. Epub 2019/06/15. eng.
K. Jabeen et al.
17. MacAskill W. Doing good better: effective altruism and a radical new way to make a difference. London: Guardian Faber Publishing; 2015.
18. Allen AM, Jung AM, Lemieux AM, Alexander AC, Allen SS, Ward KD, et al. Stressful life
events are associated with perinatal cigarette smoking. Prev Med. 2019;118:264–71.
19. Boyko EJ, Trone DW, Peterson AV, Jacobson IG, Littman AJ, Maynard C, et al. Longitudinal
investigation of smoking initiation and relapse among younger and older US military personnel. Am J Public Health. 2015;105(6):1220–9.
20. Holliday E, Gould TJ. Nicotine, adolescence, and stress: a review of how stress can modulate the negative consequences of adolescent nicotine abuse. Neurosci Biobehav Rev.
2016;65:173–84.
21. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the
United States, 2011-2012. JAMA. 2014;311(8):806–14.
22. Gore AC, Chappell V, Fenton S, Flaws JA, Nadal A, Prins GS, et al. EDC-2: the Endocrine
Society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev.
2015;36(6):E1–E150.
23. Ribeiro E, Ladeira C, Viegas S. EDCs mixtures: a stealthy hazard for human health? Toxics.
2017;5(1):5.
24. Maradonna F, Carnevali O. Lipid metabolism alteration by endocrine disruptors in animal
models: an overview. Front Endocrinol. 2018;9:654.
25. Street ME, Angelini S, Bernasconi S, Burgio E, Cassio A, Catellani C, et al. Current knowledge on endocrine disrupting chemicals (EDCs) from animal biology to humans, from pregnancy to adulthood: highlights from a national italian meeting. Int J Mol Sci. 2018;19(6):1647.
26. Grün F, Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as
emerging factors in the obesity crisis. Rev Endocr Metab Disord. 2007;8(2):161–71.
27. Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, et al. Metabolism
disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017;68:3–33.
28. Sohn J-W. Network of hypothalamic neurons that control appetite. BMB Rep. 2015;48(4):229.
29. Le Magueresse-Battistoni B, Labaronne E, Vidal H, Naville D. Endocrine disrupting chemicals in mixture and obesity, diabetes and related metabolic disorders. World J Biol Chem.
2017;8(2):108.
30. An HM, Tan YL, Tan SP, Shi J, Wang ZR, Yang FD, et al. Smoking and serum lipid profiles in
schizophrenia. Neurosci Bull. 2016;32(4):383–8. Epub 2016/03/29. eng.
31. Hallit S, Zoghbi M, Hallit R, Youssef L, Costantine R, Kheir N, et al. Effect of exclusive cigarette smoking and in combination with waterpipe smoking on lipoproteins. J Epidemiol Glob
Health. 2017;7(4):269–75. Epub 2017/11/08. eng.
32. Jain RB, Ducatman A. Associations between smoking and lipid/lipoprotein concentrations
among US adults aged >/=20 years. J Circ Biomark. 2018;7:1849454418779310. Epub
2018/06/15. eng.
33. Tonstad S. Cigarette smoking, smoking cessation, and diabetes. Diabetes Res Clin Pract.
2009;85(1):4–13. Epub 2009/05/12. eng.
34. Maddatu J, Anderson-Baucum E, Evans-Molina C. Smoking and the risk of type 2 diabetes.
Transl Res. 2017;184:101–7. Epub 2017/03/25. eng.
35. Xie XT, Liu Q, Wu J, Wakui M. Impact of cigarette smoking in type 2 diabetes development.
Acta Pharmacol Sin. 2009;30(6):784–7. Epub 2009/05/13. eng.
36. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis. 2003;45(5):405–13. Epub
2003/04/22. eng.
37. Lind PM, Lind L. Endocrine-disrupting chemicals and risk of diabetes: an evidence-based
review. Diabetologia. 2018;61(7):1495–502.
38. Fabricio G, Malta A, Chango A, Mathias PCDF. Environmental contaminants and pancreatic
beta-cells. J Clin Res Pediatr Endocrinol. 2016;8(3):257.
39. Malinska D, Wieckowski MR, Michalska B, Drabik K, Prill M, Patalas-Krawczyk P, et al.
Mitochondria as a possible target for nicotine action. J Bioenerg Biomembr. 2019;51(4):259–
76. Epub 2019/06/15. eng.
K. Jabeen et al.